2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
3
Warts
2
Neurofibromatosis 1
2
Neoplasms
2
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Retinoblastoma
1
Retinal Neoplasms
1
Prostatic Neoplasms
1
Port-Wine Stain
1
Pancreatic Neoplasms
1
Osteoma, Osteoid
1
Nevus of Ota
1
Neurofibromatoses
1
Neoplasm Metastasis
1
Mucositis
1
Lymphedema
1
Keratosis, Actinic
1
Hemangioma, Capillary
1
Head and Neck Neoplasms
1
Eye Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Bile Duct Neoplasms
1
Atrophy
1
Interventions
Etoposide
3
Carboplatin
3
Vincristine
2
Topotecan
1
Platinum Compounds
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Retinal Neoplasms
×
Lasers
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled